Efficacy and safety of insulin degludec/aspart in patients with type 2 and type 1 diabetes mellitus: real-world evidence from Indonesia. [PDF]
Zufry H +3 more
europepmc +1 more source
Insulin degludec 100 U/mL for treatment of spontaneous diabetes mellitus in dogs. [PDF]
Mott J +8 more
europepmc +1 more source
Safety and Clinical Outcomes of Insulin Degludec in Korean Patients with Diabetes in Real-World Practices: A Prospective, Observational Study. [PDF]
Lee BW +8 more
europepmc +1 more source
Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol. [PDF]
Rabbone I +10 more
europepmc +1 more source
Switching to insulin degludec/aspart penfill reusable cartridges in patients with type 2 diabetes mellitus: real-life outcomes. [PDF]
Dogan Çakır S +3 more
europepmc +1 more source
Switching from Premixed Insulin to Insulin Degludec/Insulin Aspart for the Management of Type 2 Diabetes Mellitus: Implications of a Real-World Study on Insulin Degludec Dosing. [PDF]
Wu Y, Zhang J, Li A.
europepmc +1 more source
Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia. [PDF]
El Sherif IM +3 more
europepmc +1 more source
Insulin degludec in pregestational diabetes: evidence and perspectives. [PDF]
Papaetis GS, Mikellidis KC.
europepmc +1 more source
Efficacy, safety and treatment satisfaction of transition to a regimen of insulin degludec/aspart: A pilot study. [PDF]
Yang N +10 more
europepmc +1 more source
Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes: The INHALE-3 Extension Study. [PDF]
Beck RW +11 more
europepmc +1 more source

